Pharmacokinetics/pharmacodynamics of antipseudomonal bacteriophage therapy in rats: a proof-of-concept study

World Health Organization Gordillo Altamirano, 2019, Phage therapy in the postantibiotic era, Clin Microbiol Rev, 32, 10.1128/CMR.00066-18 Salmond, 2015, A century of the phage: past, present and future, Nat Rev Microb, 13, 777, 10.1038/nrmicro3564 Schooley, 2017, Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection, Antimicrob Agents Chemother, 61, 10.1128/AAC.00954-17 Sarker, 2016, Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh, EBioMedicine, 4, 124, 10.1016/j.ebiom.2015.12.023 Jault, 2019, Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial, Lancet Infect Dis, 19, 35, 10.1016/S1473-3099(18)30482-1 Fabijan, 2019, Safety and tolerability of bacteriophage therapy in severe Staphylococcus aureus infection, bioRxiv, 619999 Chang RY, Wong J, Mathai A, Morales S, Kutter E, Britton W et al. Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection. Eur J Pharm Biopharm 2–17;121:1–13. Bonilla, 2018, Phage on tap: a quick and efficient protocol for the preparation of bacteriophage laboratory stocks, Methods Mol Biol, 1838, 37, 10.1007/978-1-4939-8682-8_4 Kropinski, 2009, Enumeration of bacteriophages by double agar overlay plaque assay, Methods Mol Biol, 501, 69, 10.1007/978-1-60327-164-6_7 Lin, 2017, Pulmonary pharmacokinetics of colistin following administration of dry powder aerosols in rats, Antimicrob Agents Chemother, 61, 10.1128/AAC.00973-17 Bulitta, 2011, Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models, AAPS J, 13, 212, 10.1208/s12248-011-9258-9 Roach, 2017, Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen, Cell Host Microbe, 22, 38, 10.1016/j.chom.2017.06.018 Henry, 2013, Predicting in vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections, Antimicrob Agents Chemother, 57, 5961, 10.1128/AAC.01596-13 Chang, 2019, Bacteriophage PEV20 and ciprofloxacin combination treatment enhances removal of Pseudomonas aeruginosa biofilm isolated from cystic fibrosis and wound patients, AAPS J, 21, 49, 10.1208/s12248-019-0315-0 Uchiyama, 2009, Blood kinetics of four intraperitoneally administered therapeutic candidate bacteriophages in healthy and neutropenic mice, Microbiol Immunol, 53, 301, 10.1111/j.1348-0421.2009.00125.x Mukerjee, 1962, Localization of cholera bacteriophage after intravenous injection, Ann Biochem Exp Med, 22, 73 Dabrowska, 2019, Phage therapy: what factors shape phage pharmacokinetics and bioavailability? Systematic and critical review, Med Res Rev, 39, 2000, 10.1002/med.21572 Tiwari, 2011, Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models, J Microbiol, 49, 994 Reynaud, 1992, Characteristics and diffusion in the rabbit of a phage for Escherichia coli 0103. Attempts to use this phage for therapy, Vet Microbiol, 30, 203, 10.1016/0378-1135(92)90114-9 Nguyen, 2017, Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers, mBio, 8, 10.1128/mBio.01874-17 Jonas, 2019, Interactions between bacteriophage, bacteria, and the mammalian immune system, Viruses, 11 Hodyra-Stefaniak, 2015, Mammalian host-versus-phage immune response determines phage fate in vivo, Sci Rep, 5, 14802, 10.1038/srep14802 Geier, 1973, Fate of bacteriophage lambda in non-immune germ-free mice, Nature, 246, 221, 10.1038/246221a0 Keller, 1959, Studies on the factors concerned in the disappearance of bacteriophage particles from the animal body, J Immunol Res, 83, 167, 10.4049/jimmunol.83.2.167 Weber-Dabrowska, 1987, Studies on bacteriophage penetration in patients subjected to phage therapy, Arch Immunol Ther Exp (Warsz), 35, 563 Pagava, 2011, What happens when the child gets bacteriophage per os?, Georgian Med News, 196–197, 101 Schultz, 1965, Relationship between blood clearance and viruria after intravenous injection of mice and rats with bacteriophage and polioviruses, J Immunol, 94, 833, 10.4049/jimmunol.94.6.833 Payne, 2003, Pharmacokinetic principles of bacteriophage therapy, Clin Pharmacokinet, 42, 315, 10.2165/00003088-200342040-00002